ALLO   $2.83  5.20% Market Closed After Close 2.828 -0.07%

Allogene Therapeutics Inc
Total Cash 444.63M
totalCashPerShare 2.126
EBITDA -256.56M
Total Debt 94.21M
quickRatio 11.972
currentRatio 12.254
Total Revenue 65.00K
debtToEquity 18.292
Revenue/Share 0.0
ROA -0.23875
ROE -0.4911
grossProfits
freeCashflow -119.75M
operatingCashflow -228.72M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -4166.246
profitMargins 0.0
enterpriseValue 216.27M
forwardPE -1.8877552
floatShares 152.10M
sharesOutstanding 209.11M
sharesShort 38.51M
sharesShortPriorMonth 38.94M
dateShortInterest
sharesPercentSharesOut 0.18%
heldPercentInsiders 0.17%
heldPercentInstitutions 0.80%
Short Ratio help_outline 19.57%
shortPercentOfFloat 0.26%
impliedSharesOutstanding
bookValue 2.464
Price To Book help_outline 1.13
earningsQuarterlyGrowth
netIncomeToCommon -279.42M
trailingEps -1.59%
forwardEps -1.47%
enterpriseToEbitda -0.84
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.32 3Q 2024
institutionsCount 240
lastUpdated Oct. 16, 2024, 8:07 p.m.